CJMB Callan JMB: Nilai perusahaan marang pendapatan

Simbol resmi perusahaan Callan JMB Corp (CJMB)

Regular supplies of orthopedic consumables ensure a steady cash flow for Callan JMB Inc (CJMB), while business success depends on government budgets and the growth rate of minimally invasive surgeries. This enterprise value-to-revenue chart captures market expectations, with the metric currently standing at 995.82. Specialized instrumentation supports the current moderate growth, while the potential for expanding product lines is only beginning to take shape.

Callan JMB Inc. (CJMB): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

CJMB (Callan JMB Inc.): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:Callan JMB Inc
Produk sing diprodhuksi Callan JMB

Stable government contracts at Callan JMB Inc (CJMB) ensure a predictable cash flow, making changes in the EV/Sales ratio a reliable tool for monitoring the business's market value. This metric compares the total enterprise value (market capitalization plus net debt) with annual revenue, allowing investors to assess the asset's real value regardless of debt load and determine the degree to which shares are overbought relative to operational efficiency.

Analisis pesaing Callan JMB Inc

ISRG - Multiplikator EV/Sales|DHR: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan BD (BDX)|Rasio nilai perusahaan marang pendapatan STERIS plc|Rasio nilai perusahaan marang pendapatan WST (West Pharmaceutical Services)|Nilai perusahaan marang pendapatan BAX (Baxter Corp)|Masimo - Rasio nilai perusahaan marang pendapatan|Stevanato Group S.p.A. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Teleflex Inc (TFX)|MMSI - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Envista Holdings Corp NVST|ICUI: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XRAY|LMAT (LeMaitre Corp) - Multiplikator EV/Sales|ATRC (AtriCure Inc) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales STAA|NAGE (ChromaDex Corp) - Nilai bisnis marang pendapatan|ZimVie Inc. - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan angiodynamics.com (ANGO)|CERS - Rasio nilai perusahaan marang pendapatan|TKNO - Multiplikator EV/Sales|Monogram Technologies Inc (MGRM) - Rasio nilai perusahaan marang pendapatan|STSS - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan InfuSystem Holdings, Inc.|Multiplikator nilai perusahaan marang pendapatan Utah Medical Products UTMD|Multiplikator EV/Sales KRMD|Rasio total nilai perusahaan marang pendapatan Nyxoah, S.A.|Microbot Medical Inc - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Pro-Dex Inc. (PDEX)|Zentek - Multiplikator EV/Sales|Elutia (ELUT) - Nilai perusahaan marang pendapatan|Milestone Scientific Inc (MLSS) - Rasio nilai perusahaan marang pendapatan|NXGL - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan RVP|Harvard Bioscience, Inc. (HBIO) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales FEMY|Multiplikator EV/Sales Meihua Medical Technologies (MHUA)|Multiplikator EV/Sales POAI (Predictive Oncology)|Multiplikator EV/Sales Atrion Corp ATRI|NeuroMetrix Corporation - Multiplikator EV/Sales